Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sho Shimazaki"'
Publikováno v:
The Journal of Clinical Pharmacology. 61:799-805
Nadolol is a hydrophilic and non-selective β-adrenoceptor blocker with a bioavailability of 30%, relatively longer half-life, negligible metabolism, and predominant renal excretion. Previous studies have reported that nadolol is a substrate of P-gly
Autor:
Shinya Sato, Shogo Horie, Yuichi Murata, Yoshida Takuya, Yuta Yasuda, Eri Nagashima, Satoshi Matsunaga, Kenji Nomiya, Kohei Endo, Sho Shimazaki, Toshiaki Matsubara
Publikováno v:
Inorganic Chemistry. 57:1504-1516
Novel intercluster compounds consisting of pentakis[(triphenylphosphane)gold]ammonium(2+) cation (1) and Keggin polyoxometalate (POM) anions, i.e., {[Au(PPh3)]5(μ5-N)}3[α-PM12O40]2 (1-PW for M = W; 1-PMo for M = Mo), were synthesized in 30–36% yi
Publikováno v:
AIJ Journal of Technology and Design. 23:725-730
Publikováno v:
AIJ Journal of Technology and Design. 21:1301-1306
Publikováno v:
Experimental Cell Research. 319:77-88
MicroRNA-1 (miR-1) has recently been suggested to function as a tumor suppressor. Its functional relevance was assessed by exploring structural and tumorigenic properties of lung cancer A549 cells stably transduced with retrovirus containing pre-miR-
Autor:
Kenji Nomiya, Kohei Endo, Yuichi Murata, Shinya Sato, Sho Shimazaki, Shogo Horie, Eri Nagashima, Yuta Yasuda, Takuya Yoshida, Satoshi Matsunaga, Toshiaki Matsubara
Publikováno v:
Inorganic Chemistry; 2/5/2018, Vol. 57 Issue 3, p1504-1516, 12p
Publikováno v:
2014 IEEE International Conference on Systems, Man & Cybernetics (SMC); 2014, p4101-4102, 2p